Phase 1 Resectable Pancreatic Cancer Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more

Dana-Farber Cancer Institute100 enrolled2 locationsNCT04789486

Recruiting

Phase 1

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)

Unresectable Pancreatic Cancer

Chengdu New Radiomedicine Technology Co. LTD.58 enrolled6 locationsNCT06278454

Recruiting

Phase 1

Safety and efficacy of faecal transplant and chemotherapy in the management of pancreatic cancer

non-resectable pancreatic cancer

Central Adelaide Local Health Network (CALHN)60 enrolled5 locationsACTRN12624000455561